Skip to Content

Most Cited

  • Feature Paper
  • Review
  • Open Access
77 Citations
63,952 Views
26 Pages

30 May 2022

Sickle cell disease and its variants constitute the most common inherited blood disorders affecting millions of individuals worldwide. Significant information regarding the nature of the genetic mutations and modifier genes that result in increased o...

(This article belongs to the Section Non Neoplastic Blood Disorders)
  • Feature Paper
  • Article
  • Open Access
28 Citations
16,858 Views
20 Pages

Burkitt Lymphoma Incidence in Five Continents

  • Sam M. Mbulaiteye and
  • Susan S. Devesa

13 July 2022

Burkitt lymphoma (BL) is a rare non-Hodgkin lymphoma first described in 1958 by Denis Burkitt in African children. BL occurs as three types, endemic, which occurs in Africa and is causally attributed to Epstein-Barr virus and P. falciparum infections...

(This article belongs to the Special Issue Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe)
  • Article
  • Open Access
25 Citations
6,425 Views
14 Pages

Barriers and Facilitators of Use of Hydroxyurea among Children with Sickle Cell Disease: Experiences of Stakeholders in Tanzania

  • Manase Kilonzi,
  • Hamu J. Mlyuka,
  • Fatuma Felix Felician,
  • Dorkasi L. Mwakawanga and ,
  • Lulu Chirande,
  • David T. Myemba,
  • Godfrey Sambayi,
  • Ritah F. Mutagonda,
  • Wigilya P. Mikomangwa and
  • Nathanael Sirili
  • + 11 authors+ 6 authors

28 November 2021

Factors contributing to low use of HU among SCD patients exist in high-income countries. The latter leaves a drift of literature on factors for low utilization of HU in developing countries. This study aimed to explore the factors influencing the use...

(This article belongs to the Section Non Neoplastic Blood Disorders)
  • Article
  • Open Access
22 Citations
5,665 Views
25 Pages

Integrative Statistics, Machine Learning and Artificial Intelligence Neural Network Analysis Correlated CSF1R with the Prognosis of Diffuse Large B-Cell Lymphoma

  • Joaquim Carreras,
  • Yara Yukie Kikuti,
  • Masashi Miyaoka,
  • Giovanna Roncador and ,
  • Juan Fernando Garcia,
  • Shinichiro Hiraiwa,
  • Sakura Tomita,
  • Haruka Ikoma,
  • Yusuke Kondo and
  • Rifat Hamoudi
  • + 8 authors+ 3 authors

10 April 2021

Tumor-associated macrophages (TAMs) of the immune microenvironment play an important role in the Diffuse Large B-cell Lymphoma (DLBCL) pathogenesis. This research aimed to characterize the expression of macrophage colony-stimulating factor 1 receptor...

(This article belongs to the Section Lymphomas)
  • Review
  • Open Access
22 Citations
11,546 Views
15 Pages

Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis

  • Gareth J. Morgan,
  • Joel N. Buxbaum and
  • Jeffery W. Kelly

5 October 2021

Non-native immunoglobulin light chain conformations, including aggregates, appear to cause light chain amyloidosis pathology. Despite significant progress in pharmacological eradication of the neoplastic plasma cells that secrete these light chains,...

(This article belongs to the Special Issue Advances in Amyloidosis: A Theme Issue in Honor of Prof. Dr. Giampaolo Merlini)
  • Feature Paper
  • Review
  • Open Access
17 Citations
22,441 Views
21 Pages

Cold Agglutinin Disease: Improved Understanding of Pathogenesis Helps Define Targets for Therapy

  • Sigbjørn Berentsen,
  • Shirley D’Sa,
  • Ulla Randen,
  • Agnieszka Małecka and
  • Josephine M. I. Vos

20 September 2022

The last 2 decades have seen great progress in understanding the pathogenesis of cold agglutinin disease (CAD) and development of effective therapies. Cold agglutinins can cause hemolytic anemia as well as peripheral circulatory symptoms such as acro...

(This article belongs to the Special Issue Waldenström Macroglobulinaemia and Related Conditions)
  • Review
  • Open Access
17 Citations
5,573 Views
27 Pages

Hematological Inflammatory Markers and Chronic Diseases: Current Evidence and Future Perspectives

  • Monica Dugăeşescu,
  • Iulia Andrei-Bitere,
  • Marina-Raluca Baciu,
  • Eva Dănescu and ,
  • Alexandru Liţescu,
  • Simina-Teodora Vidroiu,
  • Andrei Manu,
  • Maria Magdalena Constantin,
  • Ioana Roșca and
  • Elena Poenaru
  • + 6 authors+ 1 author

27 November 2025

Background/Objectives: Complete blood count (CBC)-derived markers such as the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) have gained increasing attention as accessible indicators o...

  • Feature Paper
  • Review
  • Open Access
14 Citations
11,848 Views
44 Pages

Neurovascular Manifestations of Sickle Cell Disease

  • Marialuisa Zedde,
  • Micol Quaresima,
  • Isabella Capodanno,
  • Ilaria Grisendi and ,
  • Federica Assenza,
  • Manuela Napoli,
  • Claudio Moratti,
  • Claudio Pavone,
  • Lara Bonacini and
  • Rosario Pascarella
  • + 9 authors+ 4 authors

9 August 2024

Sickle cell disease (SCD) is a hereditary blood disorder characterized by abnormal hemoglobin, leading to the sickle shape of red blood cells. It has several vascular complications and the cerebrovascular ones are among the most frequent and severe b...

(This article belongs to the Section Non Neoplastic Blood Disorders)
  • Article
  • Open Access
13 Citations
6,068 Views
10 Pages

Exploring Psychological Needs and Burden of Care in Parents of Children with Hemato-Oncological Diseases

  • Loredana Benedetto,
  • Irene Marino,
  • Francesca Ronco,
  • Grazia Iaria and ,
  • Luisa Foletti and
  • Massimo Ingrassia
  • + 1 author+ 0 author

1 August 2022

Caring for a child with an acute/life threatening disease exposes parents to multiple stressors and challenges, resulting in a physical and psychological burden. Parents experience many health-related issues and worries that often remain underestimat...

(This article belongs to the Section Leukemias)
  • Feature Paper
  • Review
  • Open Access
13 Citations
12,329 Views
18 Pages

Inflammatory and Immune Disorders Associated with Myelodysplastic Syndromes

  • Vincent Jachiet,
  • Pierre Fenaux,
  • Anna Sevoyan,
  • Yervand Hakobyan and ,
  • Lionel Ades,
  • Olivier Fain,
  • Arsène Mekinian and
  • on behalf of the MINHEMON and GFM
  • + 3 authors+ 0 author

24 May 2021

Systemic auto-inflammatory or autoimmune diseases (SIADs) develop in up to a quarter of patients with myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). With or without the occurrence of SIADs, the distribution of MDS subtypes...

(This article belongs to the Special Issue Challenges in the Treatment of Myelodysplastic Syndrome)
  • Review
  • Open Access
12 Citations
4,525 Views
10 Pages

24 November 2021

In 1992, Kaposi sarcoma herpesvirus (KSHV/HHV8) was discovered and identified as the causative agent for Kaposi sarcoma. Subsequently, the presence of this virus has been detected in a number of lymphoproliferative disorders in people living with HIV...

(This article belongs to the Special Issue Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe)
  • Article
  • Open Access
12 Citations
5,712 Views
22 Pages

CAR-T Cell Therapy for the Treatment of ALL: Eradication Conditions and In Silico Experimentation

  • Paul A. Valle,
  • Luis N. Coria,
  • Corina Plata and
  • Yolocuauhtli Salazar

18 July 2021

In this paper, we explore the application of Chimeric Antigen Receptor (CAR) T cell therapy for the treatment of Acute Lymphocytic Leukaemia (ALL) by means of in silico experimentation, mathematical modelling through first-order Ordinary Differential...

(This article belongs to the Section Leukemias)
  • Review
  • Open Access
12 Citations
9,426 Views
16 Pages

12 January 2022

The deposition of amyloid light chains (LCs) in target sites translates into tissue damage and organ dysfunction. Clinical and experimental advances have cast new light on the pathophysiology of damage in AL amyloidosis. The currently accepted view i...

(This article belongs to the Special Issue Advances in Amyloidosis: A Theme Issue in Honor of Prof. Dr. Giampaolo Merlini)
  • Review
  • Open Access
11 Citations
13,308 Views
23 Pages

Primary Cutaneous B-Cell Lymphoma: An Update on Pathologic and Molecular Features

  • Marco Lucioni,
  • Sara Fraticelli,
  • Giuseppe Neri,
  • Monica Feltri and ,
  • Giuseppina Ferrario,
  • Roberta Riboni and
  • Marco Paulli
  • + 2 authors+ 0 author

29 May 2022

Primary cutaneous B-cell lymphomas (PCBCLs) account for 25% of all primary cutaneous lymphomas. Three major types are currently recognized by the WHO classification: primary cutaneous marginal zone B-cell lymphoma (PCMZL), primary cutaneous follicle...

(This article belongs to the Special Issue Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe)
  • Review
  • Open Access
11 Citations
15,223 Views
42 Pages

Why Immunotherapy Fails in Multiple Myeloma

  • Luis Gerardo Rodríguez-Lobato,
  • Aina Oliver-Caldés,
  • David F. Moreno,
  • Carlos Fernández de Larrea and
  • Joan Bladé

22 December 2020

Multiple myeloma remains an incurable disease despite great advances in its therapeutic landscape. Increasing evidence supports the belief that immune dysfunction plays an important role in the disease pathogenesis, progression, and drug resistance....

(This article belongs to the Special Issue Immunotherapy in Myeloma: A Theme Issue in Honor of Prof. Dr. Gösta Gahrton)
  • Feature Paper
  • Review
  • Open Access
10 Citations
12,684 Views
20 Pages

Molecular Pathogenesis of Follicular Lymphoma: From Genetics to Clinical Practice

  • Cristina López,
  • Pablo Mozas,
  • Armando López-Guillermo and
  • Sílvia Beà

26 September 2022

Follicular lymphoma (FL), a generally indolent disease that derives from germinal center (GC) B cells, represents around 20–25% of all new lymphomas diagnosed in Western countries. The characteristic t(14;18)(q32;q21) translocation that places...

(This article belongs to the Special Issue Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe)
  • Article
  • Open Access
9 Citations
5,119 Views
25 Pages

9 April 2024

Background: Artificial intelligence in medicine is a field that is rapidly evolving. Machine learning and deep learning are used to improve disease identification and diagnosis, personalize disease treatment, analyze medical images, evaluate clinical...

(This article belongs to the Section Lymphomas)
  • Review
  • Open Access
9 Citations
26,945 Views
29 Pages

Review of Peripheral Blood Eosinophilia: Workup and Differential Diagnosis

  • Michael Dennis Weaver,
  • Bianca Glass,
  • Chance Aplanalp,
  • Gauri Patel and ,
  • Jeshrine Mazhil,
  • Isabella Wang and
  • Samir Dalia
  • + 2 authors+ 0 author

16 March 2024

Eosinophils are a type of granulocyte key to immune system modulation seen in a number of disease processes. Nearly every major organ system can be connected to peripheral eosinophilia through a number of different disease processes, ranging from ben...

  • Review
  • Open Access
9 Citations
5,781 Views
14 Pages

SARS-CoV-2 and Autoimmune Cytopenia

  • Ryann Quinn and
  • Irina Murakhovskaya

20 July 2021

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with a variety of clinical manifestations related to viral tissue damage, as well as a virally induced immune response. Hyperstimulation of the immune system can ser...

(This article belongs to the Section Non Neoplastic Blood Disorders)
  • Feature Paper
  • Review
  • Open Access
9 Citations
17,183 Views
26 Pages

Polyneuropathy Associated with IgM Monoclonal Gammopathy; Advances in Genetics and Treatment, Focusing on Anti-MAG Antibodies

  • Johannes P. M. van de Mortel,
  • Shirley D’Sa,
  • Alexander F. J. E. Vrancken,
  • Nicolette C. Notermans and ,
  • Josephine M. I. Vos and
  • Monique C. Minnema
  • + 1 author+ 0 author

17 October 2022

With increasing age, the chances of developing either MGUS or polyneuropathy increase as well. In some cases, there is a causative relationship between the IgM M-protein and polyneuropathy. In approximately half of these cases, IgM targets the myelin...

(This article belongs to the Special Issue Waldenström Macroglobulinaemia and Related Conditions)
  • Article
  • Open Access
9 Citations
4,976 Views
11 Pages

Persisting Endothelial Cell Activation and Hypercoagulability after COVID-19 Recovery—The Prospective Observational ROADMAP-Post COVID-19 Study

  • Grigorios T. Gerotziafas,
  • Patrick Van Dreden,
  • Theodoros N. Sergentanis,
  • Marianna Politou and ,
  • Aurélie Rousseau,
  • Matthieu Grusse,
  • Michèle Sabbah,
  • Ismail Elalamy,
  • Vasiliki Pappa and
  • Evangelos Terpos
  • + 11 authors+ 6 authors

26 January 2022

Background. Hypercoagulable state and endothelial cell activation are common alterations in patients with COVID-19. Nevertheless, the hypothesis of persistent hypercoagulability and endothelial cell activation following recovery from COVID-19 remains...

(This article belongs to the Section Coagulation)
  • Review
  • Open Access
9 Citations
4,892 Views
24 Pages

16 May 2021

Despite recent advances in diagnosis and therapy, arterial and venous thrombosis remain a major cause of morbidity and mortality in Philadelphia-negative myeloproliferative neoplasms (MPNs). Preventing and treating arterial and venous thrombosis repr...

(This article belongs to the Section Chronic Myeloid Disease)
  • Systematic Review
  • Open Access
8 Citations
7,676 Views
19 Pages

1 November 2023

Monoclonal gammopathy of undetermined significance (MGUS) is a pre-malignant plasma cell disorder with an etiology that is incompletely understood. Modifiable risk factors and genetic predispositions likely interact to increase MGUS risk in specific...

(This article belongs to the Section Plasma Cell Disorders)
  • Review
  • Open Access
8 Citations
13,184 Views
14 Pages

17 April 2024

The World Health Organization (WHO) “Classification of Tumours of Haematopoietic and Lymphoid Tissues”, published in 2001 and subsequently updated in 2008 and 2017, defined disease entities based on morphologic and phenotypic characterist...

(This article belongs to the Section Lymphomas)
  • Article
  • Open Access
8 Citations
6,146 Views
9 Pages

Patterns of Blood Transfusion in Sickle Cell Disease Hospitalizations

  • Aditi Sharma,
  • Amit Dahiya,
  • Asif Alavi,
  • Indryas Woldie and ,
  • Aditya Sharma,
  • Jeffrey Karson and
  • Vijendra Singh
  • + 2 authors+ 0 author

15 January 2024

Background: Transfusional iron overload causes significant morbidity and mortality in sickle cell disease (SCD). Nevertheless, red blood cell transfusions continue to be essential in its management. This study describes the transfusion patterns among...

(This article belongs to the Section Non Neoplastic Blood Disorders)
  • Review
  • Open Access
8 Citations
5,733 Views
15 Pages

Role and Modulation of NK Cells in Multiple Myeloma

  • Marie Thérèse Rubio,
  • Adèle Dhuyser and
  • Stéphanie Nguyen

2 April 2021

Myeloma tumor cells are particularly dependent on their microenvironment and sensitive to cellular antitumor immune response, including natural killer (NK) cells. These later are essential innate lymphocytes implicated in the control of viral infecti...

(This article belongs to the Special Issue Immunotherapy in Myeloma: A Theme Issue in Honor of Prof. Dr. Gösta Gahrton)
  • Review
  • Open Access
8 Citations
6,326 Views
36 Pages

From the Light Chain Sequence to the Tissue Microenvironment: Contribution of the Mesangial Cells to Glomerular Amyloidosis

  • Luis Del Pozo-Yauner,
  • Elba A. Turbat-Herrera,
  • Julio I. Pérez-Carreón and
  • Guillermo A. Herrera

17 March 2022

Studies carried out in the last three decades have significantly advanced our knowledge about the structural factors that drive the amyloid aggregation of the immunoglobulin light chains. Solid-state nuclear magnetic resonance and cryo-electron micro...

(This article belongs to the Special Issue Advances in Amyloidosis: A Theme Issue in Honor of Prof. Dr. Giampaolo Merlini)
  • Review
  • Open Access
8 Citations
12,651 Views
22 Pages

Future Developments in the Treatment of AL Amyloidosis

  • Foteini Theodorakakou,
  • Despina Fotiou,
  • Meletios A. Dimopoulos and
  • Efstathios Kastritis

7 February 2022

The treatment of AL amyloidosis has evolved, and outcomes have improved, but primarily for patients with low or intermediate-risk disease. Recent advances have been limited to improvements in anti-clonal therapies, which, alone, cannot change the poo...

(This article belongs to the Special Issue Advances in Amyloidosis: A Theme Issue in Honor of Prof. Dr. Giampaolo Merlini)
  • Review
  • Open Access
7 Citations
6,803 Views
14 Pages

Epigenetic Modifications in Lymphoma and Their Role in the Classification of Lymphomas

  • Sean Harrop,
  • Costas Kleanthes Yannakou,
  • Carrie Van Der Weyden and
  • Henry Miles Prince

21 February 2022

The characterisation of the lymphoma epigenome has provided insight into mechanisms involved in lymphomagenesis. Multiple lymphoma subtypes demonstrate recurrent mutations in key epigenetic regulators that have been utilised to define clinicogenetic...

(This article belongs to the Special Issue Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe)
  • Review
  • Open Access
7 Citations
12,070 Views
9 Pages

21 July 2022

The definitions of follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) are evolving in the era of personalized medicine. Early stages of the evolution of FL have been recognized. Two histological manifestations of early lesions are in...

(This article belongs to the Special Issue Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe)
  • Review
  • Open Access
7 Citations
10,245 Views
11 Pages

21 January 2022

Light chain amyloidosis is a complex disease where a small B-cell clone produces a monoclonal immunoglobulin light chain that causes deposits and specific organ dysfunction. The available treatment strategies aim to reduce or eliminate amyloidogenic...

(This article belongs to the Special Issue Advances in Amyloidosis: A Theme Issue in Honor of Prof. Dr. Giampaolo Merlini)
  • Review
  • Open Access
7 Citations
5,038 Views
12 Pages

Current Status of CAR-T Cell Therapy in Multiple Myeloma

  • Juan Luis Reguera-Ortega,
  • Estefanía García-Guerrero and
  • Jose Antonio Pérez-Simón

21 October 2021

Current data on CAR-T cell-based therapy is really promising in multiple myeloma, especially in terms of response. In heavily pretreated patients, who have already received proteasome inhibitors, immunomodulatory drugs and monoclonal antibodies, curr...

(This article belongs to the Special Issue Immunotherapy in Myeloma: A Theme Issue in Honor of Prof. Dr. Gösta Gahrton)
  • Opinion
  • Open Access
6 Citations
6,493 Views
13 Pages

9 April 2024

High-dose melphalan (HDM) plus autologous stem cell transplant (ASCT) remains a standard-of-care treatment approach for eligible patients with newly diagnosed multiple myeloma (NDMM) based on demonstrated superiority in terms of progression-free surv...

(This article belongs to the Section Plasma Cell Disorders)
  • Review
  • Open Access
6 Citations
6,797 Views
16 Pages

Transcriptional Regulation by the NFAT Family in Acute Myeloid Leukaemia

  • Shaun D. Patterson,
  • Xu Huang,
  • Heather G. Jørgensen and
  • Alison M. Michie

27 August 2021

Acute myeloid leukaemia (AML) is a haematological cancer with poor outcomes due to a lack of efficacious targeted therapies. The Nuclear Factor of Activated T Cells (NFAT) family of transcription factors is well characterised as a regulator of the ce...

(This article belongs to the Special Issue Current Topics in Acute Myeloid Leukemia)
  • Review
  • Open Access
6 Citations
13,528 Views
16 Pages

TP53 Mutant Acute Myeloid Leukemia: The Immune and Metabolic Perspective

  • Federico Zingarelli,
  • Letizia Zannoni and
  • Antonio Curti

15 November 2022

TP53 mutated/deleted acute myeloid leukemia (AML) stands out as one of the poorest prognosis forms of acute leukemia with a median overall survival not reaching one year in most cases, even in selected cases when allogenic stem-cell transplantation i...

(This article belongs to the Special Issue Memorial Issue Dedicated to Prof. Dr. Michele Baccarani: An Excellent Hematologist on Chronic Myeloid Leukemia)
  • Review
  • Open Access
6 Citations
8,357 Views
21 Pages

2 January 2021

Impaired hematopoiesis is a serious complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Bone marrow aplasia and peripheral cytopenias arise from primary and secondary graft failure or primary and secondary poor graft fu...

(This article belongs to the Section Plasma Cell Disorders)
  • Article
  • Open Access
6 Citations
6,344 Views
21 Pages

Proteomic Characterization of Spontaneous Stress-Induced In Vitro Apoptosis of Human Acute Myeloid Leukemia Cells; Focus on Patient Heterogeneity and Endoplasmic Reticulum Stress

  • Elise Aasebø,
  • Annette K. Brenner,
  • Maria Hernandez-Valladares,
  • Even Birkeland and ,
  • Håkon Reikvam,
  • Frode Selheim,
  • Frode S. Berven and
  • Øystein Bruserud
  • + 3 authors+ 0 author

17 September 2021

In vitro culture is widely used for characterization of primary human acute myeloid leukemia (AML) cells, but even when using optimized handling and culture conditions the AML cells show spontaneous in vitro apoptosis with a gradual decrease in cell...

(This article belongs to the Section Leukemias)
  • Review
  • Open Access
6 Citations
18,327 Views
11 Pages

13 February 2022

Cold agglutinin disease (CAD) is a distinct clinicopathologic entity characterized by clonal B-cell lymphoproliferative disorder in the bone marrow. B-cell gene mutations affect NF-ΚB as well as chromatin modification and remodeling pathways. C...

(This article belongs to the Special Issue Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe)
  • Review
  • Open Access
6 Citations
8,135 Views
23 Pages

13 April 2023

Waldenström macroglobulinemia (WM) is a rare, non-Hodgkin lymphoma that remains incurable. Rituximab, an anti-CD20 monoclonal antibody has been the cornerstone of treatment against WM, and its combination with an alkylator, bendamustine, achieve...

(This article belongs to the Special Issue Waldenström Macroglobulinaemia and Related Conditions)
  • Review
  • Open Access
6 Citations
7,314 Views
56 Pages

Multiple Myeloma and Precursor Plasma Cell Disorders: From Emerging Driver Mutations to Current and Future Therapeutic Strategies

  • Henry Sutanto,
  • Pradana Zaky Romadhon,
  • Vembi Rizky Fatmawati,
  • Alief Waitupu and ,
  • Bagus Aditya Ansharullah,
  • Betty Rachma,
  • Elisa Elisa,
  • Laras Pratiwi and
  • Galih Januar Adytia
  • + 4 authors+ 0 author

18 August 2025

Multiple myeloma (MM) is a malignant plasma cell disorder that evolves from precursor conditions including monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). Understanding the biological continuum and the...

(This article belongs to the Special Issue Hematopathology: Rare Hematological Diseases)
  • Review
  • Open Access
5 Citations
6,769 Views
20 Pages

The Direct and Indirect Effects of Tyrosine Kinase Inhibitors on the Cardiovascular System in Chronic Myeloid Leukemia

  • Alessandro Costa,
  • Raimondo Pittorru,
  • Giovanni Caocci,
  • Federico Migliore and ,
  • Francesco Tona,
  • Olga Mulas and
  • Giorgio La Nasa
  • + 2 authors+ 0 author

14 July 2023

Since their introduction, tyrosine kinase inhibitors (TKIs) have radically changed the treatment paradigm of Chronic Myeloid Leukemia (CML), leading to deep and lasting molecular responses and profoundly influencing survival. However, cancer-therapy-...

(This article belongs to the Special Issue Memorial Issue Dedicated to Prof. Dr. Michele Baccarani: An Excellent Hematologist on Chronic Myeloid Leukemia)
  • Review
  • Open Access
5 Citations
10,926 Views
12 Pages

30 June 2022

The Peroxisome proliferator-activated receptors (PPARs) play vital roles in regulating cellular differentiation, proliferation, and caspase-mediated cell death pathways. They are regarded as promising targets for anti-tumor drug development, particul...

  • Review
  • Open Access
5 Citations
7,842 Views
19 Pages

Genetics of Transformed Follicular Lymphoma

  • Miguel Alcoceba,
  • María García-Álvarez,
  • Jessica Okosun,
  • Simone Ferrero and ,
  • Marco Ladetto,
  • Jude Fitzgibbon and
  • Ramón García-Sanz
  • + 2 authors+ 0 author

1 October 2022

Histological transformation (HT) to a more aggressive disease–mostly diffuse large B-cell lymphoma–is considered one of the most dismal events in the clinical course of follicular lymphoma (FL). Current knowledge has not found a single bi...

(This article belongs to the Special Issue Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe)
  • Review
  • Open Access
5 Citations
7,017 Views
17 Pages

25 November 2020

Bloodstream infection (BSI) and septic shock represent one of the major limiting factors for the successful treatment of patients affected by hematologic malignancies. During the most recent years we have documented a shift in the epidemiology of bac...

(This article belongs to the Collection Exclusive Papers of the Editorial Board Members (EBMs) of Hemato)
  • Article
  • Open Access
5 Citations
7,192 Views
10 Pages

MRI versus CT and PET/CT in the Preoperative Assessment of Hodgkin and Non-Hodgkin Lymphomas

  • Francesca Maccioni,
  • Alessandro Calabrese,
  • Lucia Manganaro,
  • Carlo de Felice and ,
  • Sara Cardaccio,
  • Mariangela Lopez,
  • Arianna Cleri,
  • Gabriela Capriotti,
  • Luigi Petrucci and
  • Alessandro Pulsoni
  • + 6 authors+ 1 author

1 October 2021

(1) Background: The purpose of this study is to retrospectively compare CT, MRI, and PET/CT in detecting lymphadenopathies and extra-nodal lesions in lymphoma and in disease staging. (2) Methods: Inclusion criteria were the availability of TB (Total...

(This article belongs to the Section Radiolabeled Blood Elements and Other Imaging Modalities)
  • Review
  • Open Access
5 Citations
17,452 Views
19 Pages

Pathophysiology of Myelodysplastic Syndromes

  • Michaela Fontenay,
  • Batoul Farhat and
  • Ismael Boussaid

26 July 2021

Ineffective hematopoiesis is the major characteristic of early myelodysplastic syndromes. Its pathophysiology relies on a diversity of mechanisms supported by genetic events that develop in aging hematopoietic stem cells. Deletion and mutations trigg...

(This article belongs to the Special Issue Challenges in the Treatment of Myelodysplastic Syndrome)
  • Review
  • Open Access
5 Citations
9,399 Views
11 Pages

25 August 2021

Myelodysplastic syndromes are clonal disorders with morphological dysplasia, a variable degree of cytopenia and a risk of transformation to acute myeloid leukemia. Prognosis is very variable and is defined by blast count, cytopenia, cytogenetics and...

(This article belongs to the Special Issue Challenges in the Treatment of Myelodysplastic Syndrome)
  • Review
  • Open Access
5 Citations
4,799 Views
10 Pages

6 August 2021

The formation and deposition of fibrils derived from immunglobulin light chains is a hallmark of systemic AL amyloidosis. A particularly remarkable feature of the disease is the diversity and complexity in pathophysiology and clinical manifestations....

(This article belongs to the Special Issue Advances in Amyloidosis: A Theme Issue in Honor of Prof. Dr. Giampaolo Merlini)
  • Review
  • Open Access
5 Citations
18,001 Views
13 Pages

Bing–Neel Syndrome: Update on Diagnosis and Treatment

  • Evangeline Y. Wong,
  • Shirley D’Sa,
  • Monique C. Minnema,
  • Jorge J. Castillo and
  • Dipti Talaulikar

29 November 2022

Bing–Neel syndrome (BNS) is a rare neurological complication of Waldenström macroglobulinaemia. We highlight key issues in clinical presentation, diagnosis, and treatment while focusing on new and emerging therapies available for patients...

(This article belongs to the Special Issue Waldenström Macroglobulinaemia and Related Conditions)
XFacebookLinkedIn
Hemato - ISSN 2673-6357